EA200101067A1 - SUBSTITUTED BICYCLIC HETEROARYLIC COMPOUNDS AS ANTAGONISTS INTEGRINE - Google Patents
SUBSTITUTED BICYCLIC HETEROARYLIC COMPOUNDS AS ANTAGONISTS INTEGRINEInfo
- Publication number
- EA200101067A1 EA200101067A1 EA200101067A EA200101067A EA200101067A1 EA 200101067 A1 EA200101067 A1 EA 200101067A1 EA 200101067 A EA200101067 A EA 200101067A EA 200101067 A EA200101067 A EA 200101067A EA 200101067 A1 EA200101067 A1 EA 200101067A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- bond
- compounds
- optionally substituted
- heteroaryl
- alkylene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Данное изобретение относится к физиологически активным соединениям общей формулы (I) RZet-Het-L-Ar-L-Y, в которой Het представляет необязательно замещенное, насыщенное, частично насыщенное или полностью ненасыщенное 8-10-членное бициклическое кольцо, содержащее, по меньшей мере, один гетероатом, выбранный из О, S или N; Rпредставляет необязательно замещенный арил, гетероарил, алкил, алкенил, алкинил, циклоалкил или гетероциклоалкил; Zпредставляет простую связь, алкиленовую цепь, NR, О или S(O); Lпредставляет -R-R-связку, где Rозначает алкилен, алкенилен или алкинилен, a Rозначает простую связь, циклоалкилен, гетероциклоалкилен, арилен, гетероарилдиил, -С(=Z)-NR-, -NR-C(=Z)-, -Z-, -C(=O)-, -C(=NOR)-, -NR-, NR-C(=Z)-NR-, -SO-NR-, -NR-SO-, -O-C(=O)-, -C(=O)-O-, -NR-C(=O)-О- или -O-C(=O)-NR-; Lозначает простую связь; необязательно замещенную алкиленовую, алкениленовую, алкиниленовую, циклоалкениленовую, циклоалкиленовую, гетероарилдииловую, гетероциклоалкиленовую или ариленовую связку; -[(=O)-N(R)-С(R)(R)]-связку; -Z-R-связку; -С(=O)-CH-C(=O)-связку; -R-Z-R-связку; или -L-L-L-связку; a Y представляет карбоксил или кислотный биоизостер; а также к соответствующим N-оксидам и их пролекарствам; и фармацевтически приемлемым солям и сольватам (например, гидратам) таких соединений и их N-оксидам и пролекарствам. Такие соединения обладают ценными фармацевтическими свойствами, в частности способностью регулировать взаимодействие VCAM-1 и фибронектина с интегрином VLA-4 (α4β1).Международная заявка была опубликована вместе с отчетом о международном поиске.This invention relates to physiologically active compounds of the general formula (I) RZet-Het-L-Ar-LY, in which Het is an optionally substituted, saturated, partially saturated or fully unsaturated 8-10 membered bicyclic ring, containing at least one heteroatom selected from O, S, or N; R3 is an optionally substituted aryl, heteroaryl, alkyl, alkenyl, alkynyl, cycloalkyl, or heterocycloalkyl; Z represents a simple bond, alkylene chain, NR, O or S (O); L represents -RR-bond, where R means alkylene, alkenylene or alkynylene, a R means simple bond, cycloalkylene, heterocycloalkylene, arylene, heteroaryl diyl, -C (= Z) -NR-, -NR-C (= Z) -, -Z- , -C (= O) -, -C (= NOR) -, -NR-, NR-C (= Z) -NR-, -SO-NR-, -NR-SO-, -OC (= O) -, -C (= O) -O-, -NR-C (= O) -O- or -OC (= O) -NR-; Lose a simple connection; an optionally substituted alkylene, alkenylene, alkynylene, cycloalkenylene, cycloalkylene, heteroaryl diyl, heterocycloalkylene, or arylene bond; - [(= O) -N (R) -C (R) (R)] is a bundle; -Z-R-bunch; -C (= O) -CH-C (= O) -bond; -R-Z-R-bond; or -L-L-L-bunch; a Y is carboxyl or acid bioisostere; as well as to the corresponding N-oxides and their prodrugs; and pharmaceutically acceptable salts and solvates (for example, hydrates) of such compounds and their N-oxides and prodrugs. Such compounds have valuable pharmaceutical properties, in particular, the ability to regulate the interaction of VCAM-1 and fibronectin with VLA-4 integrin (α4β1). The international application was published along with an international search report.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9908355.2A GB9908355D0 (en) | 1999-04-12 | 1999-04-12 | Chemical compounds |
US14147099P | 1999-06-29 | 1999-06-29 | |
PCT/GB2000/001393 WO2000061580A1 (en) | 1999-04-12 | 2000-04-12 | Substituted bicyclic heteroaryl compounds as integrin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200101067A1 true EA200101067A1 (en) | 2002-04-25 |
Family
ID=10851398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200101067A EA200101067A1 (en) | 1999-04-12 | 2000-04-12 | SUBSTITUTED BICYCLIC HETEROARYLIC COMPOUNDS AS ANTAGONISTS INTEGRINE |
Country Status (6)
Country | Link |
---|---|
JP (1) | JP4864206B2 (en) |
CR (1) | CR6559A (en) |
EA (1) | EA200101067A1 (en) |
GB (1) | GB9908355D0 (en) |
YU (1) | YU71501A (en) |
ZA (1) | ZA200108302B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006056830A (en) * | 2004-08-20 | 2006-03-02 | Dai Ichi Seiyaku Co Ltd | 2-arylaminobenzoxazole derivative |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU674553B2 (en) * | 1992-10-14 | 1997-01-02 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
CA2150550A1 (en) * | 1992-12-01 | 1994-06-09 | Melissa S. Egbertson | Fibrinogen receptor antagonists |
ES2161373T3 (en) * | 1995-08-30 | 2001-12-01 | Searle & Co | DERIVATIVES OF META-GUANIDINA, UREA, THIOUREA OR AZACICLICO-AMINOBENZOIC ACID AS INTEGRINE ANTAGONISTS. |
WO1997024119A1 (en) * | 1995-12-29 | 1997-07-10 | Smithkline Beecham Corporation | Vitronectin receptor antagonists |
WO1997048697A1 (en) * | 1996-06-19 | 1997-12-24 | Rhone-Poulenc Rorer Limited | Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase |
WO1998031359A1 (en) * | 1997-01-17 | 1998-07-23 | Merck & Co., Inc. | Integrin antagonists |
JP2002511462A (en) * | 1998-04-10 | 2002-04-16 | ジー・ディー・サール・アンド・カンパニー | Heterocyclic glycyl β-alanine derivatives as vitronectin antagonists |
DE60027700T2 (en) * | 1999-02-16 | 2007-05-03 | Aventis Pharma Ltd., West Malling | BICYCLIC COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR LIGANDS |
GB9910394D0 (en) * | 1999-05-05 | 1999-07-07 | Rhone Poulenc Rorer Ltd | Chemical compounds |
-
1999
- 1999-04-12 GB GBGB9908355.2A patent/GB9908355D0/en not_active Ceased
-
2000
- 2000-04-12 YU YU71501A patent/YU71501A/en unknown
- 2000-04-12 JP JP2000610853A patent/JP4864206B2/en not_active Expired - Lifetime
- 2000-04-12 EA EA200101067A patent/EA200101067A1/en unknown
-
2001
- 2001-10-09 ZA ZA200108302A patent/ZA200108302B/en unknown
-
2002
- 2002-01-23 CR CR6559A patent/CR6559A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2002541257A (en) | 2002-12-03 |
JP4864206B2 (en) | 2012-02-01 |
YU71501A (en) | 2005-07-19 |
CR6559A (en) | 2008-11-25 |
ZA200108302B (en) | 2003-03-26 |
GB9908355D0 (en) | 1999-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20014951D0 (en) | Substituted bicyclic heteroaryl compounds as integrin antagonists | |
EA200300391A1 (en) | IMIDAZOLIC COMPOUNDS, ARYL OR HETEROARYL CONDENSED AS ANTI-INFLAMMATORY AND ANALGETIC MEANS | |
AR058065A1 (en) | CARBOXYAMINE COMPOUNDS AND USE OF THE SAME PHARMACEUTICAL COMPOSITIONS. | |
EA200100553A1 (en) | SUBSTITUTED BICYCLIC DERIVATIVES, USEFUL AS ANTICATIVE AGENTS | |
AR038883A1 (en) | COMPOUNDS THAT MODULATE THE ACTIVITY OF PPAR, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND A METHOD TO PREPARE THEM | |
ES2053587T3 (en) | NEW DERIVATIVES OF ACTIVE BENZMIDAZOLES AS ANTI-ULCERA AGENTS. | |
EA200000334A1 (en) | DERIVATIVES OF CARBOXAMIDOTHASOLES, THEIR OBTAINING, CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
EA199800752A1 (en) | PENTAFTORBENZOLSULPHONAMIDES AND THEIR ANALOGUES | |
DE60224664D1 (en) | SUBSTITUTED TETRHYDROISOCHINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
DE69626981T2 (en) | N- (2-oxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl) -3-AMIDE | |
DE60041487D1 (en) | SUBSTITUTED BICYCLIC COMPOUNDS | |
PT98362A (en) | PROCESS FOR THE PREPARATION OF TIOALQUILTIO-CEFALOSPORIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
EA200000431A2 (en) | New substituted dimeric compounds, a process for their preparation and pharmaceutical compositions containing them | |
ES2061710T3 (en) | NEW DERIVATIVES OF L-PROLINE, ITS PREPARATION AND ITS BIOLOGICAL APPLICATIONS. | |
MX9301045A (en) | PROCEDURE FOR PREPARING FIBRINOGEN RECEIVING ANTAGONISTS. | |
EA200101067A1 (en) | SUBSTITUTED BICYCLIC HETEROARYLIC COMPOUNDS AS ANTAGONISTS INTEGRINE | |
EA200400323A1 (en) | ARALKILTETRAHYDROPYRIDINES, THEIR RECEIVING AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS | |
EA200400758A1 (en) | NEW COMPOUNDS OF BENZOTHIAZINE AND BENZOTHIADIAZINE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
EA200400756A1 (en) | NEW COMPOUNDS OF BENZOTHIAZINE AND BENZOTHIADIAZINE, METHOD OF THEIR RECEIVING AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
IL74324A (en) | 3-phenyl-2-propeneamine derivatives,their preparation and pharmaceutical compositions containing them | |
ATE128705T1 (en) | SPIRO DERIVATIVES OF DIBENZOSUBERAN. | |
EA200400666A3 (en) | New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them | |
EA200101109A1 (en) | DERIVATIVES 1-TRIFTOROMETHYL-4-HYDROXY-7-PIPERIDINYL-AMINOMETHILKHROMAN | |
EA200001136A1 (en) | FUNGICIDE MIXTURES | |
ES2183500T3 (en) | NEW COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. |